Fries W - Search Results

1

Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease.

Fries W, Basile G, Bellone F, Costantino G, Viola A. Fries W, et al. Cells. 2023 Jun 26;12(13):1722. doi: 10.3390/cells12131722. Cells. 2023. PMID: 37443755 Free PMC article. Review.

2

Treatment of life-threatening type I refractory coeliac disease with long-term infliximab.

Costantino G, della Torre A, Lo Presti MA, Caruso R, Mazzon E, Fries W. Costantino G, et al. Among authors: fries w. Dig Liver Dis. 2008 Jan;40(1):74-7. doi: 10.1016/j.dld.2006.10.017. Epub 2007 Mar 26. Dig Liver Dis. 2008. PMID: 17382609

3

Clinical practice in the management of ulcerative colitis--an Italian survey.

Fries W, Costa S, Costantino G, Familiari L. Fries W, et al. Dig Liver Dis. 2008 Jul;40 Suppl 2:S214-9. doi: 10.1016/S1590-8658(08)60528-9. Dig Liver Dis. 2008. PMID: 18598991

4

Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis.

Fries W, Muja C, Crisafulli C, Costantino G, Longo G, Cuzzocrea S, Mazzon E. Fries W, et al. Int J Med Sci. 2008 Jul 3;5(4):169-80. doi: 10.7150/ijms.5.169. Int J Med Sci. 2008. PMID: 18645606 Free PMC article.

5

Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Rigoli L, Romano C, Caruso RA, Lo Presti MA, Di Bella C, Procopio V, Lo Giudice G, Amorini M, Costantino G, Sergi MD, Cuppari C, Calabro GE, Gallizzi R, Salpietro CD, Fries W. Rigoli L, et al. Among authors: fries w. World J Gastroenterol. 2008 Jul 28;14(28):4454-61. doi: 10.3748/wjg.14.4454. World J Gastroenterol. 2008. PMID: 18680223 Free PMC article.

6

Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease.

Salvarani C, Fries W. Salvarani C, et al. Among authors: fries w. World J Gastroenterol. 2009 May 28;15(20):2449-55. doi: 10.3748/wjg.15.2449. World J Gastroenterol. 2009. PMID: 19468993 Free PMC article. Review.

7

Neutrophil gelatinase-associated lipocalin levels in patients with crohn disease undergoing treatment with infliximab.

Bolignano D, Della Torre A, Lacquaniti A, Costantino G, Fries W, Buemi M. Bolignano D, et al. Among authors: fries w. J Investig Med. 2010 Mar;58(3):569-71. doi: 10.231/JIM.0b013e3181ccc20c. J Investig Med. 2010. PMID: 20061984 Clinical Trial.

8

Combined approach with biologics and surgery for enterocutaneous fistulas in Crohn's disease.

Fries W, La Malfa G, Costantino G, Repici A, Mazziotti S, Navarra G. Fries W, et al. Inflamm Bowel Dis. 2011 Feb;17(2):671-3. doi: 10.1002/ibd.21289. Inflamm Bowel Dis. 2011. PMID: 20848472 No abstract available.

9

Presti MA, Costantino G, Della Torre A, Belvedere A, Cascio A, Fries W. Presti MA, et al. Among authors: fries w. Inflamm Bowel Dis. 2011 Nov;17(11):E145-6. doi: 10.1002/ibd.21828. Epub 2011 Aug 8. Inflamm Bowel Dis. 2011. PMID: 21826767 No abstract available.

10

Thiopurine treatment in inflammatory bowel disease: response predictors, safety, and withdrawal in follow-up.

Costantino G, Furfaro F, Belvedere A, Alibrandi A, Fries W. Costantino G, et al. Among authors: fries w. J Crohns Colitis. 2012 Jun;6(5):588-96. doi: 10.1016/j.crohns.2011.11.007. Epub 2011 Dec 8. J Crohns Colitis. 2012. PMID: 22398045

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page